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Abstract
Introduction: The consumption of energy drinks has increased significantly. We report the case of a patient who
presented to our hospital with jaundice, abdominal pain, and markedly increased liver transaminases likely due to
the increased consumption of an energy drink. To the best of our knowledge, this is the first case report in the
literature linking the development of acute hepatitis to the consumption of an energy drink.
Case presentation: A 22-year-old Caucasian woman presented to our hospital with epigastric pain, nausea,
vomiting, and low-grade fever. She had been drinking 10 cans of an energy drink daily for two weeks prior to
presentation. Her physical examination revealed mild epigastric tenderness. Her initial blood tests revealed elevated
alanine aminotransferase, aspartate aminotransferase, and total bilirubin. A computed tomographic scan of the
abdomen and pelvis was normal, and the patient was discharged to home. She returned to the Emergency
Department of our hospital with worsening pain and new-onset jaundice. This time her physical examination
revealed epigastric tenderness and icteric sclera. Her aspartate aminotransferase, alanine aminotransferase, and
international normalized ratio were markedly elevated. Further radiological studies were non-specific, and she was
admitted to our hospital with a diagnosis of acute hepatitis. Her viral serology and toxicology screens were
negative. The patient was treated supportively and was discharged after resolution of her symptoms and a marked
decrease in her liver enzymes.
Conclusion: The development of acute hepatitis in this patient was most likely due to the excessive ingestion of
an energy drink, and we speculate that niacin was the culprit ingredient.
Introduction
A large number of people are consuming numerous herbal
supplements and energy drinks. To date, no cases have
linked energy drinks to hepatitis. In this case report, we
presume that the development of acute hepatitis was due
to the increased consumption of an energy drink.
Case presentation
A 22-year-old healthy Caucasian woman presented to the
Emergency Department (ED) of our hospital with epigas-
tric pain, nausea, vomiting, and low-grade fever. During
the two weeks before her presentation to the Emergency
Department, she had been consuming about 10 cans of an
energy drink daily. She denied ingestion of alcohol, other
medications, or illicit drugs. Her diet was unchanged. Initi-
ally, her physical examination was unremarkable except
for mild epigastric tenderness. Blood tests revealed an
aspartate aminotransferase (AST) level of 171U/l, an ala-
nine aminotransferase (ALT) level of 216U/l, and a total
bilirubin level of 1.7 mg/dl. A computed tomographic scan
of her abdomen and pelvis with oral and intravenous con-
trast enhancement revealed no abnormalities, and she was
discharged to home from the ED. The following day she
returned with worsening pain and new-onset jaundice.
Her examination was unchanged, with the exception of
icteric sclera. Her AST, ALT, and international normalized
ratio values were 7709U/l, 7533U/l, and 1.6, respectively.
Her total bilirubin, direct bilirubin, and albumin levels
were 3.5 mg/dl, 1.9 mg/dl and 3.8 g/dl, respectively. Her
g-glutamyl transpeptidase level was 29U/l, her acetamino-
phen level was undetectable, and her ammonia level was
23 μM/l. Her alkaline phosphatase, amylase, and lipase
levels were normal. Her toxicology screen was negative.
Ultrasound of the abdomen showed non-specific border-
line gallbladder wall thickening. She was admitted with a
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virus; cytomegalovirus; and hepatitis A, B, C, and E virus
were negative. An autoimmune work-up was not per-
formed. She received intravenous hydration and nothing
by mouth initially. She continued to improve, and her diet
was advanced. Four days later she was discharged to home
after her symptoms had resolved. Her AST, ALT, and
total bilirubin levels were 238U/l, 1947U/l, and 1.7 mg/dl,
respectively, upon discharge. She returned to the medical
clinic for follow-up after one month, and the ALT and
AST results were 22U/l and 26U/l, respectively, at that
time.
Discussion
Consumers have been indulging in increased consump-
tion of popular energy drinks. It is felt that these energy
drinks are benign and are packed with good ingredients
such as B vitamins and amino acids that do not have
adverse effects.
Energy drinks contain a blend of B vitamins, the
energy blend, and enzymes. The vitamins they contain
include vitamin B6, vitamin B3, vitamin B12, and vitamin
B9; the energy blend consists of citicoline, taurine, tyro-
sine, phenylalanine, malic acid, caffeine, and glucurono-
lactone; and the enzymes they contain include amylase,
protease, cellulase, protease, and lactase (Table 1).
Vitamin B6 is important in heme, nucleic acid, lipid,
carbohydrate, and amino acid metabolism. Toxicity
occurs when megadoses of vitamin B6 (> 500 mg/day)
are ingested [1]. Symptoms of toxicity include peripheral
neuropathy with deficits in a stocking-glove distribution,
progressive sensory ataxia, and severe impairment of
position and vibration senses. Vitamin B6 toxicity is not
linked to hepatotoxicity. The treatment of vitamin B6
toxicity is to discontinue vitamin B6 consumption, and
recovery is slow and, for some patients, incomplete.
Niacin and its derivatives are vital to cell metabolism.
They have been used for decades in the treatment of
patients with disturbed lipid and lipoprotein metabo-
lism. They have been associated with skin flushing and,
rarely, hepatotoxicity when used in pharmacological
doses (1 g/day to 5 g/day). Hepatotoxicity manifests as a
spectrum that includes mild elevation of liver enzymes,
hepatic steatosis, hepatic necrosis, and, rarely, hepatic
failure. Treatment includes discontinuation of niacin,
and usually the liver enzymes return to normal. The
smallest dose of niacin that leads to hepatotoxicity
described in the literature is 1 g/day [2]. Our patient
ingested around 300 mg of niacin daily (30 mg/can × 10
cans/day), making this the smallest reported dose that
induced niacin toxicity.
Vitamin B12 is involved in nucleic acid metabolism,
the formation of red blood cells (RBCs), and myelin
synthesis and repair. It has a very low potential for toxi-
city even when taken in large doses. This does not
imply that it has no adverse effects. Because data on the
toxic profile of vitamin B12 are limited, consumers, espe-
cially pregnant women, should be cautious when ingest-
ing large amounts of vitamin B12.
Folic acid is required for DNA synthesis, RBC synth-
esis, and cell growth. Since it is water-soluble and regu-
larly excreted by the body, toxicity as a result of excessive
ingestion does not commonly occur. According to the
National Academy of Sciences, the daily intake of folic
acid in adults should not exceed 1000 μg. Very high
doses (> 15,000 μ g/day) can cause stomach problems,
sleep problems, skin reactions, and seizures.
Citicoline functions as a neuro-protective agent. It
exhibits a very low toxicity profile in humans. In a short-
term, placebo-controlled study that compared citicoline
to placebo, transient headaches occurred in patients in
the citicoline group compared to the placebo group. No
changes or abnormalities were observed in hematologic,
biochemistry, liver function, or neurological tests in
patients in that study [3].
Taurine is a normal metabolite in humans that is
involved in the modulation of neuronal excitability,
membrane stabilization, production of bile salts, and the
detoxification of certain xenobiotics. There have been
no adequate studies done to observe toxicity and/or car-
cinogenicity linked to taurine ingestion.
Caffeine functions as a psychoactive stimulant and a
mild diuretic in humans. In large amounts, and espe-
cially over extended periods of time, caffeine can lead to
Table 1 Ingredients of the energy drink (as listed on the manufacturer’s product label)
a
Ingredients of the energy drink (serving size two fluid ounces) Amount per serving Daily value,
b %
Niacin 30 mg 150%
Vitamin B6 40 mg 2000%
Folic acid 400 μ g 100%
Vitamin B12 500 μ g 8333%
Sodium 10 mg < 1%
Energy blend 1870 mg Not known
aOther ingredients in the energy drink are purified water, natural and artificial flavors, sucralose, potassium sorbate, sodium benzoate, and
ethylenediaminetetraacetic acid;
bdaily value percentage is based on the daily intake recommended by the U.S. Food and Drug Administration.
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to a wide range of symptoms that include anxiety,
insomnia, headaches, respiratory alkalosis, and palpita-
tions. Increased use over time can lead to peptic ulcers
and gastroesophageal reflux disease. Acute caffeine
intoxication (> 300 mg/day) leads to serious symptoms
that include restlessness, arrhythmias, and psychomotor
agitation. Extremely large doses of caffeine can cause
acute psychosis, rhabdomyolysis, and even death. The
treatment of severe caffeine intoxication is generally
supportive, and dialysis may be required if the levels of
caffeine are extremely high.
Tyrosine is involved in the synthesis of neurotransmit-
ters in the brain. It has the potential for very low toxi-
city, and there have been very few reports of toxicity
reported, none of which involved hepatotoxicity.
Phenylalanine is converted to tyrosine in the body and
serves the same function as tyrosine. Toxicity symptoms
include increased blood pressure, emotional agitation,
insomnia, and headaches.
Malic acid is important in boosting immunity, main-
taining oral health, and reducing the risk of poisoning
from a build-up of toxic metals. There are no known
reported contraindications or toxicities linked to malic
acid.
D-Glucurono-g-lactone is a natural metabolite of glu-
cose and regulates the formation of glycogen. There is
very little known about the toxicity of this substance.
Conclusion
After having fairly ruled out other etiologies for our
patient’s spontaneously reversible severe hepatitis, and
after carefully reviewing the toxicity profiles of the ingre-
dients present in the energy drink she consumed, we pos-
tulated that in the face of excessive and prolonged
consumption of this energy drink, the main ingredient
most likely responsible for the development of acute
hepatitis in this patient is vitamin B3 (niacin). Although
her total ingestion of niacin was 300 mg/day, which is
well below the quantity expected to cause toxicity, there
is very little known about the toxicity profiles of some of
the other compounds or about the interactions between
them, which should be further studied. Additionally,
since these energy drinks are not regulated by the U.S.
Food and Drug Administration, the precise quantities of
the ingredients and the interactions between them are
not known. The daily increased consumption of this
drink over an extended period of two weeks would also
have contributed to the adverse effects she experienced.
In conclusion, energy drinks are not traditional food pro-
ducts and contain some constituents that, while not
unique to these products, are present in much higher
concentrations than are found in other food products
and/or natural foods. Hence the excessive ingestion of
these drinks should be avoided.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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